---
title: Drugs for Dyslipidemia
markmap:
  colorFreezeLevel: 6
---

## Drugs for Dyslipidemia

### Statins
- **Mechanism:** HMG-CoA Reductase Inhibitor
- **Primary Effect:** ↓ LDL significantly
- **Other Effects:** ↓ TG slightly, ↑ HDL slightly, Pleiotropic effects (inflammation, plaque stabilization)
- **High Yield Side Effects:**
  - Myopathy / Rhabdomyolysis (CK elevation)
  - Hepatic Dysfunction (LFT elevation - routine monitoring less common now)
  - New-onset Diabetes
  - Memory loss (rare)
- **Important Contraindications:**
  - Pregnancy & Breastfeeding
  - Active Liver Disease
- **Interactions:** CYP inhibitors (e.g., Clarithromycin, Itraconazole, Ritonavir, Cyclosporine), Gemfibrozil (increased myopathy risk)

### Fibrates
- **Mechanism:** PPAR-alpha Agonists
- **Primary Effect:** ↓ Triglycerides significantly, ↑ HDL
- **Other Effects:** ↓ VLDL synthesis, ↑ Fatty acid oxidation
- **High Yield Side Effects:**
  - Gallstones
  - Myopathy (Increased risk with Statins, esp. Gemfibrozil)
  - Liver enzyme elevation
  - Dyspepsia
- **Specific Agents:** Gemfibrozil, Fenofibrate (Fenofibrate preferred for use with statins)

### Ezetimibe
- **Mechanism:** Inhibits intestinal cholesterol absorption (NPC1L1 protein)
- **Primary Effect:** ↓ LDL
- **Use:** Often combined with Statins for additive effect
- **Side Effects:** Generally well-tolerated, diarrhea, arthralgia

### PCSK9 Inhibitors
- **Mechanism:** Monoclonal antibodies (Alirocumab, Evolocumab) that bind & inactivate PCSK9 protein -> Prevents degradation of hepatic LDL receptors -> ↑ LDL receptor recycling
- **Primary Effect:** ↓ LDL dramatically (potent)
- **Use:** Familial Hypercholesterolemia, ASCVD patients on max statin
- **Side Effects:** Injection site reactions, Nasopharyngitis, Influenza

### Bile Acid Sequestrants
- **Mechanism:** Bind bile acids in the intestine -> Prevent reabsorption -> Liver increases bile acid synthesis from cholesterol -> Upregulates LDL receptors
- **Agents:** Cholestyramine, Colestipol, Colesevelam
- **Primary Effect:** ↓ LDL
- **Other Effects:**
  - May ↑ Triglycerides (Cholestyramine)
  - Colesevelam used for Type 2 Diabetes (↓ HbA1c)
- **High Yield Side Effects:**
  - GI symptoms (Constipation, Bloating)
  - Impaired absorption of other drugs (warfarin, thyroid hormone) & fat-soluble vitamins (ADEK)

### Niacin (Nicotinic Acid)
- **Mechanism:** Inhibits VLDL synthesis & secretion by the liver -> ↓ LDL, ↓ TG; Reduces HDL catabolism -> ↑ HDL
- **Primary Effect:** ↑ HDL most effectively, ↓ TG, ↓ LDL
- **High Yield Side Effects:**
  - Flushing & Pruritus (Prostaglandin mediated - reduced by Aspirin pre-treatment)
  - Hepatotoxicity
  - Hyperglycemia
  - Hyperuricemia (Gout)
  - Peptic Ulcer exacerbation

### Omega-3 Fatty Acids
- **Mechanism:** Reduce hepatic VLDL-TG synthesis
- **Agents:** EPA (icosapent ethyl), EPA + DHA
- **Primary Effect:** ↓ Triglycerides (high doses)
- **Use:** Severe hypertriglyceridemia (>500 mg/dL)
- **Side Effects:** Fishy aftertaste, GI upset, increased bleeding risk

### INICET Buzzwords
- Myopathy
- Rhabdomyolysis
- LFT elevation
- Flushing
- Gallstones
- Constipation
- Impaired absorption
- PCSK9
- PPAR-alpha
- HMG-CoA Reductase
- NPC1L1
- Bile acid binding
- VLDL Synthesis inhibition
- Pleiotropic effects
- Combination therapy
- Familial Hypercholesterolemia
- Hypertriglyceridemia (>500)
- Aspirin pre-treatment (Niacin)
- Fenofibrate vs Gemfibrozil


